Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49b8f128d3148eb8c4a713f0eae919fc |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 |
filingDate |
2019-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a9fc397e2e6099439b0bcd9cd9f4c4f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3235c4b7e9d5890d5f91fd9bef86367 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b92153613f4ff4290e76c3d7824ec9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fc6422dfaddc05f19416377d96ec9a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e435463957befe8ee592b73104b98ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5137258cf49db46ae4e02fb774d8a6a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18e1e7fab1414641db769e913cb6087c |
publicationDate |
2021-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11040020-B2 |
titleOfInvention |
Sulfonamide pharmaceutical composition |
abstract |
A sulfonamide pharmaceutical composition. The present invention relates to a sulfonamide compound injectable preparation comprising a sulfonamide compound or a derivative thereof. The injectable preparation is prepared from the sulfonamide compound and a pharmaceutically acceptable carrier through certain preparation technologies. The sulfonamide compound injectable preparation involved in the present invention is stable and controllable in quality and effective. |
priorityDate |
2015-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |